Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of hepatitis B immunoglobulin on hepatitis B vaccine serologic response after liver transplantation
ChiCTR-TRC-11001750Phase 4Completed
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Jan 2012
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hepatitis B immune globulin and Hepatitis B vaccine in hepatitis B (HBV) (2 arms), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoint: anti-HBs titer. Started Jan 2012; status: completed.
02
Drugs
hepatitis B immune globulinHepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on ChiCTR-TRC-11001750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001750.